Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Dummer

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2001
The role of alpha beta+ T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupusB R Lawson, S I Koundouris, M Barnhouse, et al.
Dermatology (Basel, Switzerland)|June 5, 2004
T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of actionD Jullien, J C Prinz, R G B Langley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2001
Role of cyclin kinase inhibitor p21 in systemic autoimmunityM L Santiago-Raber, B R Lawson, W Dummer, et al.
Arthritis and Rheumatism|September 10, 2011
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trialW Rigby, H-P Tony, K Oelke, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC Melanoma Cooperative GroupU Keilholz, M Willhauck, D Rimoldi, et al.
Arthritis and Rheumatism|March 6, 2012
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trialP P Tak, P J Mease, M C Genovese, et al.
Human Gene Therapy|March 1, 1996
Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 geneG Stingl, E B Brŏcker, R Mertelsmann, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2001
The role of alpha beta+ T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupusB R Lawson, S I Koundouris, M Barnhouse, et al.
Dermatology (Basel, Switzerland)|June 5, 2004
T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of actionD Jullien, J C Prinz, R G B Langley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2001
Role of cyclin kinase inhibitor p21 in systemic autoimmunityM L Santiago-Raber, B R Lawson, W Dummer, et al.
Arthritis and Rheumatism|September 10, 2011
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trialW Rigby, H-P Tony, K Oelke, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC Melanoma Cooperative GroupU Keilholz, M Willhauck, D Rimoldi, et al.
Arthritis and Rheumatism|March 6, 2012
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trialP P Tak, P J Mease, M C Genovese, et al.
Human Gene Therapy|March 1, 1996
Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 geneG Stingl, E B Brŏcker, R Mertelsmann, et al.
Pageof 4